ARID2 deficiency promotes tumor progression and is associated with higher sensitivity to chemotherapy in lung cancer

The survival rate in lung cancer remains stubbornly low and there is an urgent need for the identification of new therapeutic targets. In the last decade, several members of the SWI/SNF chromatin remodeling complexes have been described altered in different tumor types. Nevertheless, the precise mec...

Descripción completa

Detalles Bibliográficos
Autores principales: Moreno, Thaidy, Monterde, Beatriz, González-Silva, Laura, Betancor-Fernández, Isabel, Revilla, Carlos, Agraz-Doblas, Antonio, Freire, Javier, Isidro, Pablo, Quevedo, Laura, Blanco, Rosa, Montes-Moreno, Santiago, Cereceda, Laura, Astudillo, Aurora, Casar, Berta, Crespo, Piero, Torres, Cristina Morales, Scaffidi, Paola, Gomez-Roman, Javier, Salido, Eduardo, Varela, Ignacio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610680/
https://www.ncbi.nlm.nih.gov/pubmed/33742126
http://dx.doi.org/10.1038/s41388-021-01748-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610680/
https://www.ncbi.nlm.nih.gov/pubmed/33742126
http://dx.doi.org/10.1038/s41388-021-01748-y

Ejemplares similares